Burning Rock Biotech (BNR) Gross Profit (2019 - 2025)
Burning Rock Biotech has reported Gross Profit over the past 7 years, most recently at $14.1 million for Q4 2025.
- For Q4 2025, Gross Profit rose 15.05% year-over-year to $14.1 million; the TTM value through Dec 2025 reached $56.5 million, up 12.22%, while the annual FY2025 figure was $57.6 million, 16.05% up from the prior year.
- Gross Profit for Q4 2025 was $14.1 million at Burning Rock Biotech, up from $13.9 million in the prior quarter.
- Over five years, Gross Profit peaked at $16.5 million in Q4 2021 and troughed at $11.0 million in Q4 2023.
- A 5-year average of $13.5 million and a median of $13.8 million in 2022 define the central range for Gross Profit.
- Biggest five-year swings in Gross Profit: skyrocketed 83.01% in 2021 and later decreased 25.06% in 2023.
- Year by year, Gross Profit stood at $16.5 million in 2021, then dropped by 11.22% to $14.7 million in 2022, then decreased by 25.06% to $11.0 million in 2023, then increased by 11.35% to $12.3 million in 2024, then rose by 15.05% to $14.1 million in 2025.
- Business Quant data shows Gross Profit for BNR at $14.1 million in Q4 2025, $13.9 million in Q3 2025, and $15.1 million in Q2 2025.